ATE383166T1 - Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration - Google Patents

Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration

Info

Publication number
ATE383166T1
ATE383166T1 AT99952872T AT99952872T ATE383166T1 AT E383166 T1 ATE383166 T1 AT E383166T1 AT 99952872 T AT99952872 T AT 99952872T AT 99952872 T AT99952872 T AT 99952872T AT E383166 T1 ATE383166 T1 AT E383166T1
Authority
AT
Austria
Prior art keywords
substances
cell regeneration
aim
oxytocin activity
oxytocin
Prior art date
Application number
AT99952872T
Other languages
English (en)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Original Assignee
Entretech Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entretech Medical Ab filed Critical Entretech Medical Ab
Application granted granted Critical
Publication of ATE383166T1 publication Critical patent/ATE383166T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT99952872T 1998-09-25 1999-09-27 Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration ATE383166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803272A SE9803272D0 (sv) 1998-09-25 1998-09-25 A drug for cell regeneration

Publications (1)

Publication Number Publication Date
ATE383166T1 true ATE383166T1 (de) 2008-01-15

Family

ID=20412731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99952872T ATE383166T1 (de) 1998-09-25 1999-09-27 Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration

Country Status (8)

Country Link
EP (1) EP1115416B1 (de)
JP (1) JP2002525337A (de)
CN (1) CN1330550A (de)
AT (1) ATE383166T1 (de)
AU (1) AU6493199A (de)
DE (1) DE69937959D1 (de)
SE (1) SE9803272D0 (de)
WO (1) WO2000018424A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915625D0 (en) * 1999-07-02 1999-09-01 Cortendo Ab Method
SE0001440D0 (sv) * 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
SE0100684D0 (sv) 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
SE0102185D0 (sv) * 2001-06-19 2001-06-19 Uvnaes Moberg Kerstin New subject-matter
SE0102910D0 (sv) * 2001-08-31 2001-08-31 Moberg Kerstin Uvnaes New use
ATE410170T1 (de) * 2003-03-27 2008-10-15 Pantarhei Bioscience Bv Verwendung von estrogenen zur behandlung von männerunfruchtbarkeit
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
DE102011118016A1 (de) * 2011-10-26 2013-05-02 Henkel Ag & Co. Kgaa Kosmetische Mittel enthaltend Oxytocin und Riechstoffe
RU2544462C1 (ru) * 2013-11-29 2015-03-20 Федеральное государственное бюджетное учреждение "Государственный научный центр Российской Федерации-Федеральный медицинский биофизический центр имени А.И. Бурназяна Федерального медико-биологического агентства" (ФГБУ "ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России") Способ профилактики развития острого панкреатита после операций на органах брюшной полости
US11414459B2 (en) 2017-09-28 2022-08-16 Kinoxis Therapeutics Pty Ltd Metabolite inspired selective oxytocin receptor agonists
JP7103886B2 (ja) * 2017-12-14 2022-07-20 花王株式会社 肌の質感改善剤の探索方法
JP2021172612A (ja) * 2020-04-24 2021-11-01 株式会社イーアール オキシトシンおよびプロトンポンプ阻害剤の組み合わせを含む薬剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4236293A1 (en) * 1992-10-23 1993-03-04 Siegfried Knauf Use of oxytocin, vasopressin and endorphins - for treatment and prevention of e.g. immunological, neurological and organ diseases and conditions caused by pituitary disorder
DE4312913A1 (de) * 1992-10-23 1994-10-13 Knauf Siegfried Medikamentenzusammensetzung Oxytocin, Vasopressin und alphabetagamma-Endorphine
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II

Also Published As

Publication number Publication date
WO2000018424A1 (en) 2000-04-06
DE69937959D1 (de) 2008-02-21
EP1115416A1 (de) 2001-07-18
JP2002525337A (ja) 2002-08-13
SE9803272D0 (sv) 1998-09-25
CN1330550A (zh) 2002-01-09
AU6493199A (en) 2000-04-17
EP1115416B1 (de) 2008-01-09

Similar Documents

Publication Publication Date Title
TR199902383T2 (xx) Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.
MX9301751A (es) Acidos amido peroxicarboxilicos.
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
DE69937959D1 (de) Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration
DE69331946D1 (de) Nukleozyme
ATE217754T1 (de) Verwendung von aerogelen in der landwirtschaft
TR199800046A3 (tr) Aktif maddeler yaratilmasi için nükleik asit olusumu.
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
DE69932236D1 (de) Elektrochemischer sensor unter verwendung von interkalativen, redox-aktiven teilen
BRPI9907866B8 (pt) composição farmacêutica, bem como seu uso
FR2695512B1 (fr) Cellule electrochimique.
BG103805A (en) Trifluoromethylalkylaminotriazolopyrimidines with fungicidal effect
EP0602984A3 (de) Elektrochemische Zelle.
PT942904E (pt) Derivados de 3-tiocarbamoilpirazol como pesticidas
DE69905906D1 (de) Kombination von zwei oder mehreren wirkstoffen unter verwendung von mikrokapsel-formulierungen
DE69835418D1 (de) Schaltungsanordnung zum schutz von teilnehmerschnittstellen
TR28071A (tr) Aktif agartma katalizörü olarak bir manganez kompleksini iceren bir agartma katalizör bilesimi.
FI963462A7 (fi) Bentsotiofeeni-, bentsofuraani- ja indolitiatsepinonit, -oksatsepinoni t ja -diatsepinonit soluadheesion estäjinä ja HIV:n estäjinä
DE69520056D1 (de) Verbindungen zur Hemmung von Thrombin
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
FI972684L (fi) Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina
TR199700261A2 (xx) Yeni Pirimido (1,2-a) indoller.
MX210235B (es) Oxiranil-triazolintionas y su empleo como microbicidas
DE60133050D1 (de) Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties